LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Coffee Shop, Bakery & Dessert Businesses for Sale
Retirement Homes for Sale
Startup Investment Opportunities
Construction & Landscaping Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Real Estate & Property Management Companies for Sale
Transport & Shipping Businesses for Sale
Restaurants for Sale
Environmental Businesses for Sale
Healthcare & Medical Businesses for Sale
Pet Franchise Opportunities
Post Office Franchises for Sale
Automotive Franchises for Sale
Printing, Signs & Publishing Franchise Opportunities
Warehouse & Storage Franchise for Sale
Child Care & Education Franchise Opportunities
Vending & Kiosk Franchises for Sale
Healthcare & Medical Franchise Opportunities
Furniture & Home Decor Franchise Opportunities
Bars & Pubs Franchises for Sale
Commercial Buildings for Sale or Lease
Office Spaces for Sale or Rent
Mixed Use Buildings for Sale or Rent
Houses & Condos for Sale or Lease
Places of Worship for Sale
Industrial Buildings for Sale or Lease
Plazas for Sale
Miscellaneous Properties for Sale or Lease
Medical Office Spaces for Sale or Rent
Industrial Units for Sale or Rent
An email will be sent to registered email address.
Please select if you are: